This webinar offers a practical synopsis of the new lung cancer biomarker testing guidelines from two of the experts who wrote the guidelines: a pathologist and an oncologist. The experts succinctly explain the context of the new lung cancer biomarker guidelines including clinical objectives, key questions and process and provide an overview of the new recommendations, emphasizing revisions of and additions to the original 2013 guidelines. Real-world implications of the new testing guidelines for patient care are covered.
- Appreciate the clinical objectives, key questions and process underlying the guidelines for lung cancer biomarker testing
- Learn the revised and additional recommendations compared to the original 2013 guideline and the evidence for them
- Understand the clinical applications of the guidelines to specific patient care
Philip T Cagle, MD, FCAP
Eric H Bernicker, MD